Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trials (Q39232473)
Jump to navigation
Jump to search
scientific article published on 10 February 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trials |
scientific article published on 10 February 2017 |
Statements
1 reference
Characterization of outcomes in patients with metastatic non-small cell lung cancer treated with programmed cell death protein 1 inhibitors past RECIST version 1.1-defined disease progression in clinical trials (English)
1 reference
Dickran Kazandjian
1 reference
Patricia Keegan
1 reference
Daniel L Suzman
1 reference
Richard Pazdur
1 reference
Gideon M Blumenthal
1 reference
10 February 2017
1 reference
1 reference
44
1 reference
1
1 reference
3-7
1 reference
Identifiers
1 reference
1 reference